New miRNA assay tool launched

29 March 2009

The USA's Affymetrix and Genisphere have launched  a new microRNA research study solution, encompassing assay, array and software.

The GeneChip miRNA Array is synthesized using a patented, high-quality  photolithography process to deliver optimal performance and includes  controls to ensure clear experimental outcomes. With the free miRNA QC  tool software from Affymetrix, users can normalize data and perform  quality control procedures for all miRNA experiments.

The FlashTag Biotin RNA Labeling Kit, created by Genisphere, is the  first commercial assay of its kind to eliminate the need for sample  purification and also provide Enzyme-Linked OligoSorbant Assay-based  quality control to monitor labeling efficiency. It is also the fastest  assay on the market, enabling researchers to complete labeling in less  than one hour. Requiring as little as 100ng of total RNA, this highly  sensitive assay can discriminate a one-nucleotide difference among  miRNAs, the companies claim.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight